Levitra Successfully Treats ED In Men With Dyslipidemi
Schering-Plough Corp. (SGP) said results of a prospective trial designed to evaluate erectile function in patients with dyslipidemia shows that Levitra, a treatment for erectile dysfunction, treats ED in men with serious common problems such as high cholesterol.
The science-based health care company said the study, double-blind and placebo-controlled, is the first to measure the safety and efficacy of a PDE 5 inhibitor in men with ED and dyslipidemia.
The company said nearly 70% of the estimated 30 million men in the U.S. who have ED also have other common conditions such as dyslipidemia (including high cholesterol), hypertension, or diabetes, which may lead to erectile dysfunction.
Related posts:
- Levitra-Therapy suitable for men with High Cholesterol
- Viagra, Levitra do not affect sperm quality
- Tenth anniversary of Viagra prompts vital discussion on men’s health
- Erectile Dysfunction May Signal A Broken Heart
- Cialis May Help Ease Pulmonary Hypertension
Comments
Leave a Reply
